Lupin Share Price
₹2031.20
as on
🔔 Approval Alert
Lupin receives USFDA approval for Lenalidomide Capsules, a generic equivalent of Revlimid, for multiple myeloma treatment.
Lupin Stock Performance
as on September 17, 2025 at 4:01 pm IST
Day's Low
Day's High
₹2,015₹2,057.8
0.80%
Downside
1.31%
Upside
52 Week's Low
52 Week's High
₹1,795.2₹2,402.911.62%
Downside
18.30%
Upside
Lupin share price movements today
- Previous Close
- ₹2,051.80
- Open
- ₹2,030.00
- Volume
- 6.72L
- Upper Circuit
- ₹2,256.90
- Lower Circuit
- ₹1,846.70
- Day's Low - High
- ₹2,015 - ₹2,057.8
- 52 Week Low - High
- ₹1,795.2 - ₹2,402.9
Lupin Historical Returns
- 1 Month Return
- + 4.24 %
- 3 Month Return
- + 5.55 %
- 1 Year Return
- -9.63 %
- 3 Year Return
- + 219.97 %
- 5 Year Return
- + 97.84 %
Lupin Fundamentals
as on September 17, 2025 at 4:01 pm IST
Market Cap
₹93,716.89 Cr
Return on Equity (ROE)
17.7
PE Ratio (TTM)
25.31
Return on capital employed (ROCE)
21.32
Industry PE ratio
42.14
Beta (LTM)
0.84
P/B Ratio
3.81
Dividend Yield
0.59
PEG Ratio
0.81
Quarterly Earnings Growth YOY
51.63
EPS (TTM)
72.41
Sector
Pharmaceuticals
Book Value
376.77
Technical Analysis
Bullish
View Technical Analysis
Lupin Stock Valuation
as on September 17, 2025 at 4:01 pm IST
Lupin in the last 5 years
Lowest (-6437.86x)
December 3, 2018
Today (25.31x)
September 16, 2025
Industry (42.14x)
September 16, 2025
Highest (517.33x)
December 2, 2022
Today’s Price to Earnings Ratio: 25.31x
Lupin Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Lupin with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 93,716.89 | 19.57% | 0.63 | 3,306 | 22,707 | |
| BUY | 11,572.58 | -8.47% | 0.52 | 413 | 2,013 | |
| BUY | 63,961.06 | 6.93% | 0.60 | 3,483 | 31,723 | |
| HOLD | 1,04,094.91 | 32.55% | 0.61 | 4,614 | 23,241 | |
| BUY | 65,726.25 | 17.62% | 0.00 | 1,414 | 6,445 |
Analyst Recommendation on Lupin Stock
Based on 37 analysts
59.46%
Buy
35.14%
Hold
5.41%
Sell
Based on 37 analysts, 59.46% of analysts recommend a 'BUY' rating for Lupin. Average target price of ₹2224.81
Source: S&P Global Market Intelligence
Lupin Share Price Target
Get share price movements and forecasts by analysts on Lupin.
What analysts predicted
8.43%UPSIDE
Target Price
₹2224.81
Current Price
₹2031.2
Analyzed by
37 Analysts
High
₹2626
Target
₹2224.81
Low
₹1896
Lupin target price ₹2224.81, a slight upside of 8.43% compared to current price of ₹2031.2. According to 37 analysts rating.
Source: S&P Global Market Intelligence
Lupin Stock's Interest Amongst Investors
Investment in Lupin Ltd Shares on INDmoney has dropped by -30.29% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Lupin Ltd Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Lupin Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Lupin Ltd Annual Profit & Loss
Figures in Rupees Crores
Lupin Ltd Cash Flow
Figures in Rupees Crores
Lupin Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Lupin Stock
Check out the Mutual Funds with significant holdings in Lupin.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Balanced Advantage Fund Direct Plan Growth Option | 1.06% | 5630582 | |
HDFC Large Cap Fund -Direct Plan - Growth Option | 2.32% | 4615980 | |
HDFC Flexi Cap Fund -Direct Plan - Growth Option | 0.97% | 4200000 | |
 Mirae Asset Large & Midcap Fund Direct Plan Growth | 1.52% | 3202378 | |
 ICICI Prudential Value Fund Direct Plan Growth | 1% | 2823402 |
Lupin Earnings and Dividends
View detailed summary of the earnings and dividend history of Lupin.
Lupin Ltd Earnings Results
Lupin Ltd’s net profit jumped 52.13% since last year same period to ₹1,219.03Cr in the Q1 2025-2026. On a quarterly growth basis, Lupin Ltd has generated 57.8% jump in its net profits since last 3-months.
Read More about Earnings ResultsLupin Ltd Dividends May,2025
In the quarter ending March 2025, Lupin Ltd has declared dividend of ₹12.00 per share on 14 May 2025 - translating a dividend yield of 0.58%.
Read More about Dividends
Indices Featuring Lupin Stock
Check stock indices that include Lupin.
Insights on Lupin Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 5.72K Cr → 6.34K Cr (in ₹), with an average increase of 9.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, LUPIN stock has moved up by 3.6%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 6.20% to 6.28% in Jun 2025 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, LUPIN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 772.52 Cr → 1.21K Cr (in ₹), with an average increase of 36.6% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 17.55% to 19.35% in Jun 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 11.9% return, outperforming this stock by 21.5%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 21.46% to 21.25% in Jun 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 46.92% to 46.90% in Jun 2025 quarter
Lupin Stock Futures & Options Contracts
View the latest movement in Lupin Futures & Options, including strike prices, expiry dates, and percentage changes.
Lupin Options
Lupin Futures
About Lupin Ltd
The company's top products include a wide range of prescription and over-the-counter drugs, including antibiotics, cardiovascular medications, antidiabetics, and anti-asthmatics. Lupin Ltd also manufactures and markets a variety of branded products, including Metoject, Lupitac, and Lupizole. In addition, the company produces a number of popular generic drugs, such as Amlodipine, Montelukast, and Cetirizine.
Lupin Ltd is one of the world's leading manufacturers of APIs, with a portfolio that includes more than 200 APIs and intermediates. The company also produces a range of animal health products, such as veterinary vaccines, feed supplements, and pet care products.
Revenue: ₹6,163.75Cr as on June 2025 (Q1 FY26)
Net Profit: ₹1,221.46Cr as on June 2025 (Q1 FY26)
Listing date: 30 Nov, 1994
Chairperson Name: M D Gupta
| Organisation | Lupin Ltd |
| Industry | Pharmaceuticals |
| CEO | M D Gupta |
| E-voting on shares | Click here to vote |
FAQs
What is Lupin share price today?
Lupin share price today stands at ₹2031.2 as on at the close of the market. Lupin share today touched a day high of ₹2057.8 and a low of ₹2015.
What is the 52 week high and 52 week low range for Lupin share?
Lupin touched a 52 week high of ₹2402.9 and a 52 week low of ₹1795.2. Lupin share price today i.e. is closed at ₹2031.2, which is -15.47% down from its 52 week high and 13.15% up from its 52 week low.
What is Lupin's market capitalisation today?
Lupin market capitalisation is ₹93,716.89 Cr as on .
How to buy Lupin shares?
To buy Lupin shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for LUPIN or Lupin Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Lupin shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Lupin trading volume today?
Lupin trading volume is 6.72L as on . This means that 6.72L shares of Lupin were bought and sold on the stock market during today's trading session.